Over three decades since the release of my second report as Australia’s first human rights commissioner, one of my longtime ...
Company plans new, confirmatory Phase 3 clinical trial of LYR-210 for treatment of chronic rhinosinusitis (CRS) without nasal polyps, on path to NDA submission - ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果